跳至主要内容
临床试验/NCT04261868
NCT04261868Unknown不适用

Virtual Reality Game Playing in Amblyopia Therapy

Hamideh Sabbaghi0 个研究点目标入组 50 人开始时间: 2020年3月11日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
50
主要终点
Best Corrected Visual Acuity (BCVA)

研究概览

简要总结

Background: "Amblyopia is a neurodevelopmental disorder in both monocular and binocular functions and it extends even beyond the primary visual integration centers", therefore, amblyopia is not a "lazy eye" but it is a "lazy brain".

Purpose: The investigators aimed to compare the visual outcome of occlusion therapy with virtual reality game playing as a new therapy on amblyopic children.

Methods: This RCT was performed on 50 children with unilateral amblyopia ,4 to 10 years old. They were randomly divided to case and control (each= 25) groups. case group were trained binocularly using the virtual reality games through head set for one hour a day, 5 days in a week for 4 to 6 weeks. Controls occluded their non- amblyopic eyes, 2, 4 and 6 hours for mild (0.2 to 0.3 LogMAR), moderate (0.3 to 0.6 LogMAR) and severe (BCVA < 0.6 LogMAR) amblyopia, respectively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
4 Years 至 10 Years(Child)
性别
All
接受健康志愿者
是

入选标准

  • •- The best corrected visual acuity worse than 0.3 LogMAR

排除标准

  • •Patients with abnormal fixation
  • •Patients with neurological problems
  • •Patients with any types of ocular pathologies

研究组 & 干预措施

Virtual Reality

Experimental

Dichoptic playing games with fine stimulation will present to the amblyopic eye.

干预措施: Virtual Reality (Device)

Patching

Active Comparator

Non- amblyopic eye will be recommended to patch.

干预措施: Patching (Other)

结局指标

主要结局

Best Corrected Visual Acuity (BCVA)

时间窗: baseline and 6 months after training

Change from baseline BCVA at 6 months

次要结局

未报告次要终点

研究者

发起方
Hamideh Sabbaghi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hamideh Sabbaghi

Principal Investigator

Shahid Beheshti University of Medical Sciences

相似试验